The patient died of cardiac arrest 3 days after admission.<h4>Discussion</h4>Progressive unexplained dyspnoea after receiving programmed cell death protein 1 monoclonal antibody should prompt clinicians to consider PAH and RHC. This evidence concerns the gene PDCD1 and pulmonary arterial hypertension.